Home/Pipeline/Stem Cell Therapy for Neurodegenerative Diseases

Stem Cell Therapy for Neurodegenerative Diseases

Alzheimer’s, Parkinson’s, ALS, Multiple Sclerosis

Under DevelopmentActive

Key Facts

Indication
Alzheimer’s, Parkinson’s, ALS, Multiple Sclerosis
Phase
Under Development
Status
Active
Company

About GIOSTAR

GIOSTAR is a private, clinical-stage biotechnology company focused on translating stem cell science into therapeutic treatments. The company leverages a network of scientific advisors with ties to prestigious US research institutions and operates a major stem cell hospital in India through a government partnership. Its pipeline is broad and pre-commercial, targeting over 30 conditions from blood diseases to neurological disorders, though it appears to be in early clinical or development stages for most programs. The company's model combines therapeutic development with direct patient treatment services at its international centers.

View full company profile